 |
Prominent publications by Weili Gu
INTRODUCTION: Infected pancreatic necrosis (IPN) and its related septic complications are the major causes of death in patients with acute necrotising pancreatitis (ANP). Therefore, the prevention of IPN is of great clinical value, and immunomodulatory therapy with thymosin alpha 1 may be beneficial. This study was designed to test the hypothesis that the administration of thymosin alpha 1 during the acute phase of ANP will result in a reduced incidence of IPN.
METHODS AND ANALYSIS: This ...
| Also Ranks for: Infected Pancreatic Necrosis | thymosin alpha | acute necrotising pancreatitis | ipn admission | secondary endpoints |
Plasma levels of soluble receptor for advanced glycation end products in patients with acute respiratory distress syndrome.
[ PUBLICATION ]
The acute respiratory distress syndrome (ARDS) is a syndrome of acute respiratory failure associated with severe inflammation and diffuse alveolar damage. Recent studies have demonstrated that the soluble receptor for advanced glycation end products (sRAGE) plays an important role in the pathogenesis of ARDS. The aim of this study was to ascertain whether plasma levels of sRAGE were elevated in ARDS patients compared with appropriate controls. Furthermore, we explored whether plasma ...
| Also Ranks for: Soluble Receptor | acute respiratory | distress syndrome | advanced glycation | srage levels |
Mid-term results and risks of isolated tricuspid valve reoperation following left-sided valve surgery
[ PUBLICATION ]
OBJECTIVES: Tricuspid valve reoperation (TVR) following left-sided valve surgery (LSVS) is a high-risk procedure. This study was conducted to analyse the mid-term results and risks of isolated TVR following LSVS.
METHODS: From May 2007 to December 2016, 91 patients who underwent isolated TVR following LSVS were enrolled in this study.
RESULTS: The patients comprised 23 men and 68 women with a mean age of 57.5 ± 8.0 years (range 33-75 years). The in-hospital mortality rate was 2.2% (2 of ...
| Also Ranks for: Tricuspid Valve | 5 years | underwent isolated | female heart | hospital mortality |
Weili Gu: Influence Statistics
| Concept | World rank |
|---|---|
| enhancing tα1 | #21 |
| tα1 developed | #21 |
| injection tα1 | #21 |
| tα1 7 | #22 |
| randomised 254 | #22 |
| ipn highly | #22 |
| earlyonset immunosuppression | #22 |
| immune enhancement patients | #22 |
| predicted severe anpmethodswe | #22 |
| tα1 254 placebo | #23 |
| 46 254 patients | #23 |
| receive tα1 | #23 |
| ipn admission | #23 |
| tα1 254 | #23 |
| 479 508 | #23 |
| tα1 16 | #23 |
| incidence ipn | #24 |
| 254 assigned | #25 |
| abstract backgroundaims | #26 |
| prevent ipn | #26 |
| 254 placebo admission | #26 |
| 40 254 157 | #26 |
| 254 placebo | #27 |
| advent symptoms | #30 |
| early tα1 | #33 |
| early tα1 treatment | #33 |
| prevent infected | #34 |
| anp reduce | #35 |
| pancreatitis immune | #36 |
| ipn compared | #36 |
| bleeding 63 | #38 |
| severe anp | #40 |
| development ipn | #42 |
| enhancement prevent | #46 |
| 46 254 | #48 |
| patients tα1 | #49 |
| 181 placebo | #50 |
| 7 matching | #52 |
| highly morbid complication | #55 |
| developed ipn | #61 |
| failure 106 | #65 |
| necrosis double | #94 |
| placebo admission | #98 |
Key People For Immune Enhancement
Weili Gu:Expert Impact
Concepts for whichWeili Guhas direct influence:Immune enhancement, Infected pancreatic necrosis, Ipn admission, Soluble receptor, Tricuspid valve, Patients tα1, Insulation materials, Thymosin alpha.
Weili Gu:KOL impact
Concepts related to the work of other authors for whichfor which Weili Gu has influence:Tricuspid valve, Soluble receptor, Immune enhancement, Natural fibres, Polytraumatized patients, Normal saline, Cytokeratin fragment.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |